随机二期癌症临床试验验验证预测生物标志物
Baoshan Zhang1, Jong-Mu Sun2, Myung-Ju Ahn2
1Department of Biostatistics and Bioinformatics, Duke University, Durham, NC 27705, USA.
Biomedicines
|October 26, 2024
概括
这项研究引入了设计和分析II期癌症临床试验的新方法,以验证预测生物标志物. 该方法确保了生物标志物分层试验的稳健的样本大小选择和分析策略.
科学领域:
- 在瘤学瘤学.
- 临床试验设计 临床试验设计
- 生物标志物的验证
背景情况:
- 使用生物标志物的癌症临床试验的设计需要仔细考虑试验阶段,生物标志物类型和验证状态.
- 二期试验对于验证预测生物标志物以指导向治疗至关重要.
研究的目的:
- 提出设计和分析II期癌症临床试验的方法,重点是验证预测生物标志物.
- 为临床试验环境中生物标志物验证提供实用方法.
主要方法:
- 建议采用随机试验设计,根据生物标志物状态对患者进行分层,并将他们分配到向或非向治疗中.
- 瘤反应是通过相互作用测试验证生物标志物的主要终点.
- 开发了一种样本大小计算方法,考虑了逻辑转换和原始响应率.
主要成果:
- 拟议的样本大小方法应用于现实世界随机二期试验.
- 模拟显示了测试统计和样本大小方法在各种场景中的强大性能.
结论:
- 开发的方法为在II期癌症试验中验证预测生物标志物的实用框架.
- 模拟结果支持所选择的相互作用模型,并为生物标志物分层试验中的样本大小和分析提供指导.
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K